Butterfly Network (BFLY) Competitors

Butterfly Network (NYSE:BFLY) and NovoCure (NASDAQ:NVCR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

Is BFLY or NVCR more profitable?

NovoCure has a net margin of -27.13% compared to Butterfly Network's net margin of -71.79%. Butterfly Network's return on equity of -30.53% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-71.79%	-30.53%	-21.80%
NovoCure	-27.13%	-47.74%	-13.79%

Which has more risk & volatility, BFLY or NVCR?

Butterfly Network has a beta of 2.45, suggesting that its share price is 145% more volatile than the S&P 500. Comparatively, NovoCure has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in BFLY or NVCR?

37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 84.6% of NovoCure shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by insiders. Comparatively, 5.5% of NovoCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has better valuation and earnings, BFLY or NVCR?

Butterfly Network has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$82.06M	4.28	-$72.49M	-$0.28	-4.98
NovoCure	$605.22M	2.20	-$168.63M	-$1.56	-7.63

Does the media favor BFLY or NVCR?

In the previous week, Butterfly Network and Butterfly Network both had 4 articles in the media. Butterfly Network's average media sentiment score of 0.71 beat NovoCure's score of 0.38 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NovoCure	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend BFLY or NVCR?

Butterfly Network currently has a consensus price target of $3.00, suggesting a potential upside of 115.05%. NovoCure has a consensus price target of $28.79, suggesting a potential upside of 141.69%. Given NovoCure's higher possible upside, analysts clearly believe NovoCure is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
NovoCure	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Butterfly Network beats NovoCure on 9 of the 15 factors compared between the two stocks.